cabozantinib
exelixis
['blcsm', 'cabozantinib', 'urothelial']
single-agent cabozantinib stalls as maintenance therapy in advanced urothelial cancer #asco22 #blcsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.